CI
ADPT icon

Cordant Inc’s Adaptive Biotechnologies ADPT Stock Holding History

Cordant Inc’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
+100
New +$1.53K ﹤0.01% 120

Other funds holding ADPT

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Cordant Inc's ADPT Position: Q2 2026 in Review

Cordant Inc opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 100 shares worth $2.15K. The stake represents ﹤0.01% of the portfolio and ranks #120 among its holdings.

22 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Cordant Inc held 100 shares of Adaptive Biotechnologies worth $2.15K as of Q2 2026.
  • Adaptive Biotechnologies was a new Cordant Inc position in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #120 holding.
  • 22 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.